778 related articles for article (PubMed ID: 10898527)
21. Voltage-shift of the current activation in HERG S4 mutation (R534C) in LQT2.
Nakajima T; Furukawa T; Hirano Y; Tanaka T; Sakurada H; Takahashi T; Nagai R; Itoh T; Katayama Y; Nakamura Y; Hiraoka M
Cardiovasc Res; 1999 Nov; 44(2):283-93. PubMed ID: 10690305
[TBL] [Abstract][Full Text] [Related]
22. State-dependent barium block of wild-type and inactivation-deficient HERG channels in Xenopus oocytes.
Weerapura M; Nattel S; Courtemanche M; Doern D; Ethier N; Hebert T
J Physiol; 2000 Jul; 526 Pt 2(Pt 2):265-78. PubMed ID: 10896755
[TBL] [Abstract][Full Text] [Related]
23. Voltage-dependent profile of human ether-a-go-go-related gene channel block is influenced by a single residue in the S6 transmembrane domain.
Sănchez-Chapula JA; Ferrer T; Navarro-Polanco RA; Sanguinetti MC
Mol Pharmacol; 2003 May; 63(5):1051-8. PubMed ID: 12695533
[TBL] [Abstract][Full Text] [Related]
24. Inactivation gating determines nicotine blockade of human HERG channels.
Wang HZ; Shi H; Liao SJ; Wang Z
Am J Physiol; 1999 Sep; 277(3):H1081-8. PubMed ID: 10484431
[TBL] [Abstract][Full Text] [Related]
25. Saxitoxin is a gating modifier of HERG K+ channels.
Wang J; Salata JJ; Bennett PB
J Gen Physiol; 2003 Jun; 121(6):583-98. PubMed ID: 12771193
[TBL] [Abstract][Full Text] [Related]
26. HERG K(+) channel activity is regulated by changes in phosphatidyl inositol 4,5-bisphosphate.
Bian J; Cui J; McDonald TV
Circ Res; 2001 Dec; 89(12):1168-76. PubMed ID: 11739282
[TBL] [Abstract][Full Text] [Related]
27. Dynamic control of deactivation gating by a soluble amino-terminal domain in HERG K(+) channels.
Wang J; Myers CD; Robertson GA
J Gen Physiol; 2000 Jun; 115(6):749-58. PubMed ID: 10828248
[TBL] [Abstract][Full Text] [Related]
28. Molecular determinants of dofetilide block of HERG K+ channels.
Ficker E; Jarolimek W; Kiehn J; Baumann A; Brown AM
Circ Res; 1998 Feb; 82(3):386-95. PubMed ID: 9486667
[TBL] [Abstract][Full Text] [Related]
29. Differential effects of amino-terminal distal and proximal domains in the regulation of human erg K(+) channel gating.
Viloria CG; Barros F; Giráldez T; Gómez-Varela D; de la Peña P
Biophys J; 2000 Jul; 79(1):231-46. PubMed ID: 10866950
[TBL] [Abstract][Full Text] [Related]
30. Molecular basis for the lack of HERG K+ channel block-related cardiotoxicity by the H1 receptor blocker cetirizine compared with other second-generation antihistamines.
Taglialatela M; Pannaccione A; Castaldo P; Giorgio G; Zhou Z; January CT; Genovese A; Marone G; Annunziato L
Mol Pharmacol; 1998 Jul; 54(1):113-21. PubMed ID: 9658196
[TBL] [Abstract][Full Text] [Related]
31. Effect of lanthanum on voltage-dependent gating of a cloned mammalian neuronal potassium channel.
Tytgat J; Daenens P
Brain Res; 1997 Feb; 749(2):232-7. PubMed ID: 9138723
[TBL] [Abstract][Full Text] [Related]
32. Protein kinase A-mediated phosphorylation of HERG potassium channels in a human cell line.
Wei Z; Thomas D; Karle CA; Kathöfer S; Schenkel J; Kreye VA; Ficker E; Wible BA; Kiehn J
Chin Med J (Engl); 2002 May; 115(5):668-76. PubMed ID: 12133532
[TBL] [Abstract][Full Text] [Related]
33. Blockade of the HERG human cardiac K(+) channel by the antidepressant drug amitriptyline.
Jo SH; Youm JB; Lee CO; Earm YE; Ho WK
Br J Pharmacol; 2000 Apr; 129(7):1474-80. PubMed ID: 10742304
[TBL] [Abstract][Full Text] [Related]
34. Modulation of rat erg1, erg2, erg3 and HERG K+ currents by thyrotropin-releasing hormone in anterior pituitary cells via the native signal cascade.
Schledermann W; Wulfsen I; Schwarz JR; Bauer CK
J Physiol; 2001 Apr; 532(Pt 1):143-63. PubMed ID: 11283231
[TBL] [Abstract][Full Text] [Related]
35. Functional characterization of the C-terminus of the human ether-à-go-go-related gene K(+) channel (HERG).
Aydar E; Palmer C
J Physiol; 2001 Jul; 534(Pt 1):1-14. PubMed ID: 11432987
[TBL] [Abstract][Full Text] [Related]
36. The antidepressant drug fluoxetine is an inhibitor of human ether-a-go-go-related gene (HERG) potassium channels.
Thomas D; Gut B; Wendt-Nordahl G; Kiehn J
J Pharmacol Exp Ther; 2002 Feb; 300(2):543-8. PubMed ID: 11805215
[TBL] [Abstract][Full Text] [Related]
37. Use-dependent 'agonist' effect of azimilide on the HERG channel.
Jiang M; Dun W; Fan JS; Tseng GN
J Pharmacol Exp Ther; 1999 Dec; 291(3):1324-36. PubMed ID: 10565858
[TBL] [Abstract][Full Text] [Related]
38. High-affinity blockade of human ether-a-go-go-related gene human cardiac potassium channels by the novel antiarrhythmic drug BRL-32872.
Thomas D; Wendt-Nordahl G; Röckl K; Ficker E; Brown AM; Kiehn J
J Pharmacol Exp Ther; 2001 May; 297(2):753-61. PubMed ID: 11303067
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of the current of heterologously expressed HERG potassium channels by flecainide and comparison with quinidine, propafenone and lignocaine.
Paul AA; Witchel HJ; Hancox JC
Br J Pharmacol; 2002 Jul; 136(5):717-29. PubMed ID: 12086981
[TBL] [Abstract][Full Text] [Related]
40. High affinity open channel block by dofetilide of HERG expressed in a human cell line.
Snyders DJ; Chaudhary A
Mol Pharmacol; 1996 Jun; 49(6):949-55. PubMed ID: 8649354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
